Metraipolis › archive › dc_901487048639

Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women — Europe PMC PMID:33206002

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33206002
DOI
10.1289/ehp7017
License (as archived)
CC0-1.0
Archived
2026-11-06T22:11:40.360Z
SHA-256 of the archived text
21ab43d3f95e0b149dbe93d5fe16c138e1361c4c0b659a4b8707bdd9c5d7cf26
Stable URL of this page
https://metraipolis.com/documento/dc_901487048639

How to cite

Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women — Europe PMC PMID:33206002 — Europe PMC (en), https://europepmc.org/article/MED/33206002 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_901487048639 (Metraipolis archive dc_901487048639, sha256 21ab43d3f95e0b149dbe93d5fe16c138e1361c4c0b659a4b8707bdd9c5d7cf26)
BibTeX
@misc{dc901487048639,
  title = {Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women — Europe PMC PMID:33206002},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33206002},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_901487048639; sha256 21ab43d3f95e0b149dbe93d5fe16c138e1361c4c0b659a4b8707bdd9c5d7cf26},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33206002. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Injectable contraceptive use is common, with 74 million users worldwide. Use of the injectable contraceptive depot medroxyprogesterone acetate (DMPA) is associated with bone mineral density loss. We hypothesize that increased bone resorption with DMPA use allows for mobilization of the toxic metal lead stored in bone to blood, presenting users with increased systemic exposure to lead. Objective: The objective of our study was to investigate the association between current DMPA use and blood lead concentrations. Methods: We conducted a cross-sectional analysis using enrollment data from the Study of Environment, Lifestyle & Fibroids (SELF), a cohort of 1,693 African-American women who were 23-35 years of age. Data on DMPA use were collected by computer-assisted telephone interview. Blood lead concentrations were measured in whole blood samples among 1,548 participants (91% of cohort). We estimated the adjusted percent difference in blood lead concentrations and 95% confidence intervals (CI) between current DMPA users and nonusers using multivariable linear regression. Results: Geometric mean blood lead concentration was 0.69μg/dL (95% CI: 0.67, 0.71). After adjustment, current DMPA users (7% of cohort) had blood lead concentrations that were 18% higher than those of nonusers (95% CI: 8%, 29%). Similar associations were observed with additional analyses to assess for potential bias from smoking, DMPA-induced amenorrhea, use of estrogen-containing contraceptives, having given birth in the prior year, and history of medical conditions or current medication use associated with bone loss. Discussion: Our results indicate that current DMPA use is associated with increased blood lead concentrations. Further research, particularly in populations highly exposed to lead, is warranted to consider tradeoffs between the adverse effects of lead on human health and the importance of DMPA as a contraceptive option to prevent unintended pregnancy. https://doi.org/10.1289/EHP7017.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: Environmental health perspectives, 2020 (prima pubblicazione 2020-11-18).
Identificativi: PMID 33206002 · PMCID PMC7673223 · DOI 10.1289/ehp7017.
Pagina: https://europepmc.org/article/MED/33206002 — https://doi.org/10.1289/ehp7017. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-06T22:06:39.896Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.